LexDanaLexDanabeta
Inventor

Gerald Juergen Roth

Inventor
Biberach, DE

Overview

42→
Patents
2003–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 42 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds46%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations39%
A61KPreparations for medical, dental or toiletry purposes8%
C07CAcyclic or carbocyclic compounds6%
C04BLime, magnesia1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
11,104,665Pyridazines202110,154,990Medicaments for the treatment or prevention of fibrotic diseases2018RE046630'Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity'20179,340,510'Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereof'20169,340,507'Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity'20169,278,954'Pyrrolidine derivatives, pharmaceutical compositions and uses thereof'20169,169,205'Pyrrolidine derivatives, pharmaceutical compositions and uses thereof'20159,102,624'Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity'20159,006,450'Compounds, pharmaceutical compositions and uses thereof'20158,962,641'Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof'20158,877,754'Compounds, pharmaceutical compositions and uses thereof'20148,877,741'Pyrrolidine derivatives, pharmaceutical compositions and uses thereof'20148,835,472'Compounds, pharmaceutical compositions and uses thereof'20148,765,959'Piperidine derivatives'20148,759,528'Piperidine derivatives, pharmaceutical compositions and uses thereof'20148,623,860'Azetidine derivatives, pharmaceutical compositions and uses thereof'20148,618,132'Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds'20138,530,461'Azetidine derivatives'20138,530,460'Azetidine derivatives'20138,067,590'Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds'20117,989,474'Use of Lck inhibitors for treatment of immunologic diseases'20117,858,616'Indolinone derivatives substituted in the 6 position, their preparation and their use as medicaments'20107,605,176'β-ketoamide compounds with MCH antagonistic activity'20097,592,358'Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds'20097,592,373'Amide compounds with MCH antagonistic activity and medicaments comprising these compounds'20097,560,480'Alkyl-containing 5-acylindolinones, the preparation thereof and their use as medicaments'20097,547,703'Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments'20097,524,862'Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds'20097,514,468'Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions'20097,452,911'Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds'20087,351,719'Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds'20087,176,231'Aryl-containing 5-acylindolinones, the preparation thereof and their use as medicaments'20077,169,936'Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments'20077,166,615'Substituted indolinones, preparation thereof and their use as pharmaceutical compositions'20077,160,901'Substituted indolinones, preparation thereof and their use as pharmaceutical compositions'20077,148,249'Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments'20067,119,093'3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition'20066,858,641'Substituted indolinones'20056,855,710'Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs'20056,794,395'Substituted indolinones, their manufacture and their use as medicaments'20046,762,180'Substituted indolines which inhibit receptor tyrosine kinases'20046,638,965'Substituted indolinones, preparation thereof and their use as pharmaceutical compositions'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2013Patents assigned to BOEHRINGER INGELHEIM PHARMA (17)· patent assignee history
2003–2018Based in Biberach, DE· patent location history
2007–2021Patents assigned to BOEHRINGER INGELHEIM INT (25)· patent assignee history
2011–2016Patents assigned to ROTH GERALD JUERGEN (15)· patent assignee history
2013–2016Patents assigned to FLECK MARTIN (12)· patent assignee history
2013–2016Patents assigned to NOSSE BERND (12)· patent assignee history
2013–2017Based in Biberach an der Riss, DE· patent location history
2021Based in Warthausen, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BOEHRINGER INGELHEIM INT252007–2021
BOEHRINGER INGELHEIM PHARMA172003–2013
ROTH GERALD JUERGENself152011–2016
FLECK MARTIN122013–2016
NOSSE BERND122013–2016
Locations
LocationPatentsSpan
Biberach, DE242003–2018
Biberach an der Riss, DE172013–2017
Warthausen, DE12021